Crossmark

HDL functionality in type 1 diabetes: enhancement of cholesterol efflux capacity in relationship with decreased HDL carbamylation after improvement of glycemic control

Crossref DOI link: https://doi.org/10.1186/s12933-022-01591-9

Published Online: 2022-08-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Denimal, Damien https://orcid.org/0000-0001-5454-954X
Monier, Serge

Simoneau, Isabelle https://orcid.org/0000-0002-9092-1908
Duvillard, Laurence https://orcid.org/0000-0001-9320-793X
Vergès, Bruno https://orcid.org/0000-0001-8957-629X
Bouillet, Benjamin https://orcid.org/0000-0002-4317-6714
License Information

Text and Data Mining valid from 2022-08-12

Version of Record valid from 2022-08-12
More Information

Article History

Received: 3 June 2022

Accepted: 4 August 2022

First Online: 12 August 2022

Declarations

:

: This study was approved by our regional ethics committee. Written informed consent was obtained for all patients included in the study.

: Not applicable.

: The authors declare that they have no competing interests.

Document is current

Any future updates will be listed below